SCHEMBL3240849

SCHEMBL3240849

NC(=O)c1ccc(C2=NOCC2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 10/20 0.41
MKNK2 Q9HBH9 10/20 0.41
IKBKB O14920 1/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
CYP17A1 P05093 1/20 0.39
MAP4K4 O95819 2/20 0.39
TSHR P16473 1/20 0.39
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
CYP1A2 P05177 1/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1499925 0.84 CRBN (0.45) MKNK1MKNK2CA12CA1CA2
SCHEMBL667853 0.76 ESR1 (0.42) ALDH1A1NPC1TP53HPGDNFKB1
SCHEMBL30594257 0.72 MAOB (0.39) ALDH1A1KDM4ENPC1LMNAGAA
SCHEMBL1002578 0.70 CA2 (0.67) MKNK1MKNK2CA12CA1CA2
SCHEMBL28896993 0.68 CLK4 (0.44) CA12CA1CA2CA9CA14
SCHEMBL6070922 0.68
Terephthalamide SCHEMBL23774 0.67 PARP1 (0.71) CA12CA1CA2CA9CA14
SCHEMBL15748062 0.66 MKNK1 (0.53) MKNK1MKNK2IKBKBCA12CA1
SCHEMBL13617393 0.66 MKNK1 (0.62) MKNK1MKNK2CA12CA1CA2
SCHEMBL28610546 0.66 CA2 (0.56) MKNK1MKNK2CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239759-A1 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS INTERVET INC. (US) 2024-07-18 US disclosed
US-20240239759-A1 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS INTERVET INC. (US) 2024-07-18 US disclosed
EP-4387451-A1 ORAL FELINE FEED AND METHODS FOR CONTROLLING TICK INFESTATIONS IN A FELINE In the Bowl Animal Health, Inc. (US) 2024-06-26 EP disclosed
US-20240165085-A1 ORAL FELINE FEED AND METHODS FOR CONTROLLING TICK INFESTATIONS IN A FELINE IN THE BOWL ANIMAL HEALTH, INC. 2024-05-23 US disclosed
US-20240156789-A1 ORAL FELINE FEED AND METHODS FOR CONTROLLING FLEA INFESTATIONS IN A FELINE IN THE BOWL ANIMAL HEALTH, INC. 2024-05-16 US disclosed
EP-4358737-A2 ORAL FELINE FEED AND METHODS FOR CONTROLLING FLEA INFESTATIONS IN A FELINE In the Bowl Animal Health, Inc. (US) 2024-05-01 EP disclosed
CN-117915782-A Oral feed for felines and method for controlling flea infestations in felines 碗中动物健康公司 2024-04-19 CN disclosed
CN-117769356-A Oral feed for felines and method for controlling tick infestations in felines 碗中动物健康公司 2024-03-26 CN disclosed
CN-117500498-A Method for controlling flea and tick infestations in mammals 碗中动物健康公司 2024-02-02 CN disclosed
EP-4304357-A1 ORAL CANINE FEED AND METHODS FOR CONTROLLING TICK INFESTATIONS IN A CANINE In the Bowl Animal Health, Inc. (US) 2024-01-17 EP disclosed
EP-2545777-A1 Isoxazoline compositions and their use as antiparasitics Intervet International B.V. (NL) 2013-01-16 EP disclosed
US-20110059988-A1 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS INTERVET INTERNATIONAL B.V. 2011-03-10 US disclosed
US-20110059988-A1 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS INTERVET INTERNATIONAL B.V. 2011-03-10 US disclosed
CN-101778566-A Isoxazoline compositions and their use as antiparasitics INTERVET INT BV 2010-07-14 CN disclosed
CN-101778566-A Isoxazoline compositions and their use as antiparasitics INTERVET INT BV 2010-07-14 CN disclosed
EP-2190289-A2 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS Intervet International B.V. (NL) 2010-06-02 EP disclosed
EP-2190289-A2 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS Intervet International B.V. (NL) 2010-06-02 EP disclosed
WO-2009024541-A3 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS INTERVET INTERNATIONAL B.V. (NL) 2010-04-01 WO disclosed
WO-2009024541-A2 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS INTERVET INTERNATIONAL B.V. (NL) 2009-02-26 WO disclosed
WO-2009024541-A2 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS INTERVET INTERNATIONAL B.V. (NL) 2009-02-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240156789-A1 ORAL FELINE FEED AND METHODS FOR CONTROLLING FLEA INFESTATIONS IN A FELINE CAT, F7, PIGO MKNK1 2599/4885MKNK2 2708/4885IKBKB 2441/4885
US-20240165085-A1 ORAL FELINE FEED AND METHODS FOR CONTROLLING TICK INFESTATIONS IN A FELINE CAT, F7, PIGO MKNK1 1839/4885MKNK2 1751/4885IKBKB 2437/4885
US-20240239759-A1 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS PRDX5, TUBA3C, TUBA1C MKNK1 3173/4885MKNK2 1694/4885IKBKB 3899/4885
US-20110059988-A1 ISOXAZOLINE COMPOSITIONS AND THEIR USE AS ANTIPARASITICS PRDX5, TUBA3C, AADAC MKNK1 3009/4885MKNK2 1584/4885IKBKB 3829/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.